Page 165 - MEMOCiberer014-ENG

• Epidemiology of hematological neoplasias . Gene expression marker study and search of polymor- phisms accounting for familial aggregations .
• Approach to study of internalization of nanoparticles containing small drug molecules on monocytes and macrophages and application to treat deposit diseases .
• Analysis of the effect of pharmacological chaperones on protein mutants in Gaucher Disease . • Plasma miRNAs profile in Haematological malignancies and predictor use to developed acute leukae-
mia .
Most relevant scientific articles
• pastores Gm, petaKoV m, GiralDo p, rosenbaum H, szer J, DeeGan pb, amato DJ, menGel e, tan es, cHertKoFF r, brill-almon e, zimran a . A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase . Blood Cells Mol Dis 2014; 2014 Dec . 53(4):253-60 . PubMed
• García-Gutiérrez V, puerta Jm, maestro b, casaDo montero lF, muriel a, molina HurtaDo Jr, perez-encinas m, moreno romero mV, suñol pb, sola Garcia r, De paz r, ramirez sancHez mJ, osorio s, mata Vazquez mi, martinez lópez J, sastre Jl, portero mDe l, bautista G, Durán nieto ms, GiralDo p, Jiménez Jambrina m, burGaleta c, ruiz areDonDo J, peñarrubia mJ, requena mJ, FernánDez Valle mDel c, calle c, paz coll a, HernánDez-riVas Já, Franco osorio r, cano p, tallón pérez D, FernánDez De la mata m, GarriDo pl, steeG- mann Jl . Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor? Am J Hematol 2014; Nov . 89(11):E206-11 . PubMed
• oriol a, GiralDo p, KotsianiDis i, couturier c, olie r, anGermunD r, corso a . Efficacy and safety of bor- tezomib-based retreatment at the first relapse in multiple myeloma patients: a retrospective study . Hematology 2014; Dec 10 . [Epub ahead of print] . PubMed
• meDrano-enGay b, irun p, GerVas-arruGa J, anDraDe-campos m, anDreu V, alFonso p, pocoVi m, GiralDo p . Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease . Blood Cells Mol Dis 2014; 2014 Dec . 53(4):171-5 . PubMed
• benboubKer l, Dimopoulos ma, Dispenzieri a, catalano J, belcH ar, caVo m, pinto a, Weisel K, luDWiG H, baHlis n, banos a, tiab m, DelForGe m, caVenaGH J, GeralDes c, lee JJ, cHen c, oriol a, De la rubia J, qiu l, WHite DJ, binDer D, anDerson K, FermanD Jp, moreau p, attal m, KniGHt r, cHen G, Van oostenDorp J, Jacques c, erVin-Haynes a, aVet-loiseau H, Hulin c, Facon t . Lenalidomide and dexamethasone in trans- plant-ineligible patients with myeloma . N Engl J Med 2014; Sep 4 . 371(10):906-17 . PubMed
Institution: Instituto Aragonés de Ciencias de la Salud Contact: Instituto Aragonés de Ciencias de la Salud . Hospital Miguel Servet . Campus San Francisco . Avda . de CIBA . 50009 Zaragoza · Tel .: (+34) 670 285 339 / 976 761 283 / 976 762 842
www .ciberer .es 165